Literature DB >> 33111260

pH Impedance Parameters Associated with Improvement in GERD Health-Related Quality of Life Following Anti-reflux Surgery.

Morgan K Johnson1, Manasa Venkatesh1, Natalie Liu1, Catherine R Breuer1, Amber L Shada1, Jacob A Greenberg1, Anne O Lidor1, Luke M Funk2,3.   

Abstract

INTRODUCTION: pH impedance testing is the most sensitive diagnostic test for detecting gastroesophageal reflux disease (GERD). The literature remains inconclusive on which preoperative pH impedance testing parameters are associated with an improvement in heartburn symptoms after anti-reflux surgery. The objective of this study was to evaluate which parameters on preoperative pH impedance testing were associated with improved GERD health-related quality of life (GERD-HRQL) following surgery.
METHODS: Data from a single-institution foregut database were used to identify patients with reflux symptoms who underwent anti-reflux surgery between 2014 and 2020. Acid and impedance parameters were extracted from preoperative pH impedance studies. GERD-HRQL was assessed pre- and postoperatively with a questionnaire that evaluated heartburn, dysphagia, and the impact of acid-blocking medications on daily life. Patient characteristics, fundoplication type, and four pH impedance parameters were included in a multivariable linear regression model with improvement in GERD-HRQL as the outcome.
RESULTS: We included 108 patients (59 Nissen and 49 Toupet fundoplications), with a median follow-up time of 1 year. GERD-HRQL scores improved from 22.4 (SD ± 10.1) preoperatively to 4.2 (± 6.2) postoperatively. In multivariable analysis, a normal preoperative acid exposure time (p = 0.01) and Toupet fundoplication (vs. Nissen; p = 0.03) were independently associated with greater improvement in GERD-HRQL.
CONCLUSIONS: Of the four pH impedance parameters that were investigated, a normal preoperative acid exposure time was associated with greater improvement in quality of life after anti-reflux surgery. Further investigation into the critical parameters on preoperative pH impedance testing using a multi-institutional cohort is warranted.

Entities:  

Keywords:  Anti-reflux surgery; GERD; QoL; pH impedance

Mesh:

Year:  2020        PMID: 33111260      PMCID: PMC7855403          DOI: 10.1007/s11605-020-04831-z

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 3.  Fundoplication versus medical management of gastroesophageal reflux disease: systematic review and meta-analysis.

Authors:  Nadja Rickenbacher; Thomas Kötter; Michael M Kochen; Martin Scherer; Eva Blozik
Journal:  Surg Endosc       Date:  2013-09-10       Impact factor: 4.584

4.  Twenty-four-hour pH monitoring of the distal esophagus. A quantitative measure of gastroesophageal reflux.

Authors:  L F Johnson; T R Demeester
Journal:  Am J Gastroenterol       Date:  1974-10       Impact factor: 10.864

5.  The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data.

Authors:  B L Weusten; J M Roelofs; L M Akkermans; G P Van Berge-Henegouwen; A J Smout
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

6.  The outcome of fundoplication in patients with GERD based on abnormal impedance testing.

Authors:  M E Glasgow; C M Dunst; W F Abdelmoaty; N Setthavongsack; H Creasey; D Davila Bradley; K M Reavis; L L Swanstrom; S R Demeester
Journal:  Surg Endosc       Date:  2019-08-09       Impact factor: 4.584

7.  Long-term outcome of laparoscopic Nissen and laparoscopic Toupet fundoplication for gastroesophageal reflux disease: a prospective, randomized trial.

Authors:  John M Shaw; Philippus C Bornman; Marie D Callanan; Ian J Beckingham; David C Metz
Journal:  Surg Endosc       Date:  2009-09-30       Impact factor: 4.584

8.  Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication.

Authors:  J A Broeders; W A Draaisma; A J Bredenoord; D R de Vries; H G Rijnhart-de Jong; A J Smout; H G Gooszen
Journal:  Br J Surg       Date:  2009-09       Impact factor: 6.939

9.  Comparison of results from a randomized trial 1 year after laparoscopic Nissen and Toupet fundoplications.

Authors:  Oliver O Koch; Adolf Kaindlstorfer; Stavros A Antoniou; Ruzica Rosalia Luketina; Klaus Emmanuel; Rudolph Pointner
Journal:  Surg Endosc       Date:  2013-01-30       Impact factor: 4.584

10.  Comparison of generic (SF-36) vs. disease-specific (GERD-HRQL) quality-of-life scales for gastroesophageal reflux disease.

Authors:  V Velanovich
Journal:  J Gastrointest Surg       Date:  1998 Mar-Apr       Impact factor: 3.267

View more
  1 in total

1.  Randomized controlled trial of robotic-assisted versus conventional laparoscopic fundoplication: 12 years follow-up.

Authors:  F Lang; A Huber; K F Kowalewski; H G Kenngott; F Billmann; A T Billeter; L Fischer; V V Bintintan; C N Gutt; B P Müller-Stich; F Nickel
Journal:  Surg Endosc       Date:  2022-01-25       Impact factor: 3.453

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.